Atlas Trials

A Study of APS03118 in Advanced Solid Tumors Harboring RET Mutations or Fusions

Clinical trial NCT05653869 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05653869
Sponsor
Applied Pharmaceutical Science, Inc.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
RET-altered Solid Tumors
Start date
2023-02-06
Primary completion
2026-10-01
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.